FindTrial
Sign In

Clinical trial of Chinese herbal on the therapy for patients with coronary slow flow

Clinical trial of Chinese herbal on the therapy for patients with coronary slow flow

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061758
Enrollment
Unknown
Registered
2022-07-02
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Slow Flow

Interventions

control group:conventional therapy
experimental group:Chinese herbal

Sponsors

The First Medical Center of Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. patients identified as "coronary slow flow" were evaluated by coronary angiography and corrected thrombolysis in myocardial infarction frame count.

Exclusion criteria

Exclusion criteria: 1. myocardial infarction; 2. history of cardiac surgery or percutaneous coronary intervention; 3. severe uncontrolled hypertension or left ventricular hypertrophy; 4. severe hepatic or renal insufficiency; 5. heart valve disease; 6. cardiomyopathy; 7. severe infection; 8. malignant neoplasm; 9. cardiac insufficiency NYHA class III or higher; 10. coronary artery spasm and dilatation; 11. atrial fibrillation; 12. anemia; 13. thyroid disease; 14. pacing rhythm.

Design outcomes

Primary

MeasureTime frame
General information;Myocardial enzymes;—

Secondary

MeasureTime frame
Effectiveness evaluation;Cytokines;—

Countries

China

Contacts

Public ContactMuyang Yan
yanmy301@sina.com(010)66937086

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026